Trial Profile
Ceftaroline Salvage Therapy for MRSA Bacteremia Following Vancomycin Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 15 Oct 2015 New trial record